Close
!(973) 604-5500

Newsletter

Back to Article List

White House Announces Drug Pricing Deal and Retirement Access Expansion

Share this article...
White House Announces Drug Pricing Deal and Retirement Access Expansion

The Trump administration this week announced two separate policy initiatives aimed at lowering healthcare costs and expanding retirement savings access, signaling a continued focus on affordability and financial security for American households.

One effort centers on prescription drug pricing, while the other targets retirement plan access for workers without employer-sponsored options.

Drug Pricing Deal Aims to Lower Costs Through “Most Favored Nation” Policy

The White House announced a new agreement with Regeneron Pharmaceuticals as part of its ongoing “most favored nation” (MFN) drug pricing initiative.

Under the agreement, state Medicaid programs will gain access to pricing for Regeneron drugs that matches the lowest prices paid in other developed countries, a model intended to reduce costs for U.S. patients.

Officials said the deal could generate hundreds of millions of dollars in savings across Medicaid programs and applies to both current and future medications developed by the company.

The agreement also includes provisions for reduced direct-to-patient pricing on certain drugs, including a cholesterol medication that will be offered at a lower price through a federal discount platform.

The Regeneron deal represents the latest in a series of agreements with pharmaceutical manufacturers tied to the MFN policy, which seeks to align U.S. drug prices with those paid in other countries.

Policy Reflects Broader Push to Align U.S. Drug Prices Globally

The MFN approach builds on earlier executive actions aimed at reducing prescription drug costs by benchmarking prices internationally.

Under the policy, drug manufacturers are encouraged—or in some cases required—to offer U.S. prices that do not exceed those available in comparable foreign markets.

Supporters of the initiative argue that it addresses long-standing concerns that Americans pay more for prescription drugs than patients in other developed countries.

However, questions remain about how consistently the pricing model will be applied and whether it will produce sustained savings across the healthcare system.

Executive Order Targets Retirement Plan Access Gap

In a separate move, Donald Trump signed an executive order aimed at expanding access to retirement savings options for workers without employer-sponsored plans.

The order directs the Treasury Department to develop a new online platform, expected to launch as TrumpIRA.gov, where individuals can compare and open low-cost individual retirement accounts (IRAs).

The initiative is designed to address a significant coverage gap: an estimated 50 to 56 million U.S. workers lack access to workplace retirement plans, including many part-time workers, contractors, and small business employees.

Federal Matching Contributions for Lower-Income Workers

The retirement initiative also ties into the federal “Saver’s Match” program, which provides a government-funded contribution to eligible individuals who save for retirement.

Under current guidelines, qualifying low- and moderate-income workers may receive a matching contribution of up to $1,000 annually, deposited directly into their retirement accounts.

The program builds on provisions established in earlier legislation and is expected to take effect in conjunction with the rollout of the new platform.

Focus on Expanding Access Rather Than Creating New Plans

Officials emphasized that the executive order does not create a new government-run retirement system. Instead, it is intended to connect individuals with existing private-sector IRA options that meet federal standards for low fees and accessibility.

The platform is expected to include:

  • Simplified enrollment tools

  • Standardized investment options

  • No minimum balance requirements

The effort is modeled in part on the federal Thrift Savings Plan, which provides retirement options for government employees.

Broader Policy Context

Taken together, the two initiatives reflect a broader policy approach focused on affordability in two key areas of household finances:

  • Healthcare costs, particularly prescription drugs

  • Long-term retirement savings

Both areas have been identified as ongoing challenges for American consumers, with policymakers across administrations attempting to expand access and reduce costs.

The White House announcements highlight two parallel policy priorities: lowering prescription drug prices through international price alignment and expanding retirement savings access for workers outside traditional employer-sponsored plans.

While both initiatives are expected to roll out over the coming months and years, their long-term impact will depend on implementation details, participation rates, and potential legislative action.


PDF
Printable PDF

Have a Question About This Topic?

I confirm this is a service inquiry and not an advertising message or solicitation. By clicking “Submit”, I acknowledge and agree to the creation of an account and to the Terms of Use and Privacy Policy.

NEVER MISS A STORY.

Sign up for our newsletters and get our articles delivered right to your inbox.